Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for posttraumatic stress disorder (PTSD).
For more information, please visit www.recoverystudy.com or www.clinicaltrials.gov (NCT03841773).
|10/24/18||S-1||General form of registration statement for all companies including face-amount certificate companies||48|
|10/24/18||8-K||Current report filing||67|
|10/02/18||8-K||Current report filing||138|
|09/13/18||8-K||Current report filing||3|
|09/10/18||8-K||Current report filing||135|
|09/07/18||4||Olukotun Adeoye Y
|09/07/18||S-1||General form of registration statement for all companies including face-amount certificate companies||43|
|09/07/18||3||Olukotun Adeoye Y
|09/07/18||8-K||Current report filing
|08/23/18||8-K||Current report filing||3|